首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Therapeutic advances in drug safety

缩写:

ISSN:2042-0986

e-ISSN:2042-0994

IF/分区:3.4/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引534
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Amani M Cobert,Catherine Helms,Chris Larck et al. Amani M Cobert et al.
Background: Trastuzumab emtansine (T-DM1) is an anti-HER2 antibody-drug conjugate indicated for the treatment of HER2-positive breast cancer. One of the most severe adverse events reported with T-DM1 is hepatotoxicity. Th...
Marina A Malikova Marina A Malikova
Pharmacovigilance is a field where communication is crucial, and exchange of information is expected to be done in a timely manner. Information from individual case reports is transmitted from pharmaceutical industry and health professional...
Alan J Poots,Barry Jubraj,Emily Ward et al. Alan J Poots et al.
Research into the practice of medication review is developing across the world in response to the ever-increasing burden of inappropriate polypharmacy. Education, training and support of undergraduates and novice practitioners to equip them...
Senol Kobak Senol Kobak
Secukinumab is an IL-17A antagonist that has proven efficacy in the treatment of patients with ankylosing spondylitis (AS) and psoriatic arthritis. Side effects of the drug include infections, skin rashes, and allergic reactions. Raynaud's ...
Kazeem Adeola Oshikoya,Ibrahim Abayomi Ogunyinka,Comfort Kunak Ogar et al. Kazeem Adeola Oshikoya et al.
Background: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous adverse reactions (SCARs). There is scant literature on the characteristics and causes of these conditions among the Nig...
Aaron Jason Bilek,Yuval Levy,Haneen Kab et al. Aaron Jason Bilek et al.
Background: In complex older patients, inappropriate medication use and polypharmacy (IMUP) are commonplace and increasing exponentially. Reducing IMUP is a challenge in multiple clinical contexts, including acute admissi...
Thomas M Polasek,Carl M J Kirkpatrick,Amin Rostami-Hodjegan Thomas M Polasek
Adverse drug reactions (ADRs) have traditionally been managed by trial and error, adjusting drug and dose selection reactively following patient harm. With an improved understanding of ADRs, and the patient characteristics that increase sus...
Elise Carpenter,Divita Singh,Eric Dietrich et al. Elise Carpenter et al.
Background: Review of clinical data on andexanet alfa for the reversal of factor Xa (FXa) inhibitor associated anticoagulation. Data sources: ...